Gastrointestinal injury due to medicinal agents.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003092:Colitis / Q000139:chemically induced; D003108:Colonic Diseases / Q000139:chemically induced; D004378:Duodenal Diseases / Q000139:chemically induced; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced; D004935:Esophageal Diseases / Q000139:chemically induced; D004941:Esophagitis / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D007410:Intestinal Diseases / Q000139:chemically induced; D007421:Intestine, Small / Q000187:drug effects; D008286:Malabsorption Syndromes / Q000139:chemically induced; D011189:Potassium Chloride / Q000009:adverse effects; D012597:Sclerosing Solutions / Q000009:adverse effects; D013272:Stomach Diseases / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000970:Antineoplastic Agents; D012597:Sclerosing Solutions; D011189:Potassium Chloride